comparemela.com
Home
Live Updates
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion : comparemela.com
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion
DEERFIELD, Ill. & BOSTON & NEW YORK--(BUSINESS WIRE)--May 8, 2023--
Related Keywords
New York
,
United States
,
Germany
,
Shanghai
,
China
,
Singapore
,
Hong Kong
,
Indiana
,
Amsterdam
,
Noord Holland
,
Netherlands
,
Mauritius
,
London
,
City Of
,
United Kingdom
,
Luxembourg
,
Berlin
,
Boston
,
Massachusetts
,
Bloomington
,
Beijing
,
San Francisco
,
California
,
Mumbai
,
Maharashtra
,
India
,
Houston
,
Texas
,
Deerfield
,
America
,
Kerrie Cohen
,
Carmine Petrone
,
Andrea Johnson
,
Joee Almeida
,
Warburg Pincus
,
Ruoxi Chen
,
John Maldonado
,
Twitter
,
Sotera Health
,
Advent International
,
Iodine Software
,
Biopharma Solutions
,
Moelis Company
,
Summit Health
,
Syneos Health
,
Linkedin
,
Global Healthcare Exchange
,
Sullivan Cromwell
,
Cleary Gottlieb Steen Hamilton
,
Baxter International Inc
,
Suven Pharmaceuticals Cohance Lifesciences
,
Facebook
,
Advent International Inc
,
Chief Executive Officer
,
Managing Partner
,
Managing Director
,
Cohance Lifesciences
,
Modernizing Medicine
,
Ensemble Healthcare Partners
,
Weinberg Partners
,
Truist Securities
,
Cleary Gottlieb Steen
,
North America
,
Latin America
,
Anna Epstein
,
Business Wire
,
Illinois
,
comparemela.com © 2020. All Rights Reserved.